A new paper in Genome Biology and Evolution, published by Oxford University Press, shows that rapid evolution in bats may account for the animals’ extraordinary ability to both host and survive infections as well as avoid cancer. https://www.eurekalert.org/news-releases/1001498# Bats are exceptional among mammals not only for their ability to fly but also their long lives, low cancer …
After the US Food and Drug Administration authorized new monovalent COVID vaccines on early last week, the Centers of Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices backed the decision a day later with a nearly unanimous vote in favour of universal XBB-containing shots. https://www.medscape.com/viewarticle/996378? Reports of a mutating virus and COVID hospitalisations of about 17,000 people a …
The U.S. Agency for International Development (USAID) has prematurely ended a $125 million program aimed at identifying viruses that might harm humans in animals. Many see this as a fallout from the concern that researchers studying bat viruses may have triggered the COVID-19 pandemic. https://www.science.org/content/article/u-s-cancels-program-aimed-identifying-potential-pandemic-viruses? USAID launched the program, known as the Discovery & Exploration …
The US Department of Health and Human Services (HHS) has announced its first list of 10 prescription drugs whose prices will be open for negotiation in 2023 and 2024. Any settled price will become effective in 2026. The HHS will be working through the Centres for Medicare and Medicaid Services (CMS) under the provisions of …
The U.S. Food and Drug Administration (FDA) has approved a vaccine given to pregnant women to protect babies from respiratory syncytial virus (RSV). The virus causes severe lung infections that are the leading cause of U.S. infant hospitalizations. https://www.science.org/content/article/rsv-vaccine-scientific-advisory-panels-and-biodiversity-hot-spot-risk? Pregnant people who receive the vaccine, called Abrysvo and made by Pfizer, can pass protective antibodies …
FDA approves RSV maternal vaccine; The latest health stories from around the world Read More »
A new COVID vaccine is due out next month, but health experts and analysts say it is likely to be coolly received even as hospitalizations from “Eris”, a variant of the Omicron form of the coronavirus, rise around the country. https://www.reuters.com/business/healthcare-pharmaceuticals/new-covid-vaccines-are-way-eris-variant-rises-2023-08-14/ Fortunately, early data suggests that the new shots will still be effective against Eris. …
Following the detection of a new strain of the novel coronavirus, data put out by the World Health Organization (WHO) shows an 80 per cent rise in Covid-19 cases around the world. https://indianexpress.com/article/world/who-global-covid-19-cases-rise-updates-8889491/ The variant, known as EG.5 or “Eris”, is related to an Omicron subvariant called XBB.1.9.2, and is growing in prevalence globally, with …
The UK is nearly “flying blind” when it comes to COVID this autumn, experts have said, amid an increase in cases. While the UK Health Security Agency (UKHSA) continues to track some metrics of COVID, including hospitalization numbers, many of the community surveillance studies tracking infection levels have finished. www.theguardian.com/world/2023/aug/05/uk-almost-flying-blind-on-COVID-this-autumn-experts-say? Now experts have said the …
UK COVID-19 surveillance “flying blind”; The latest health stories from around the world Read More »
To the relief of biomedical research advocates, a US Senate spending panel has approved a modest budget increase of 2% for the National Institutes of Health (NIH). The bump to $47.8 billion roughly matches President Joe Biden’s request for the 2024 fiscal year that begins this fall. Although below the rate of biomedical inflation, it …
The pharmaceutical company Johnson & Johnson (J&J) in mid-July agreed to help make a therapy critical to fighting drug-resistant tuberculosis (TB) more widely available and affordable. J&J said it would allow competitors to market generic versions of the lifesaving drug, bedaquiline, in 44 low- and middle-income countries (LMICs) where the company has active patents. www.science.org/content/article/news-glance-ben-franklin-s-anticounterfeiting-science-s-english-language-barrier? …
Health Issues India is a web portal that tracks key health stories and issues in India. On our website, you will find a guide to some of the latest trends, research, reports and journals on health. We provide original interviews and opinions of specialists as well as our own commentary on issues and events.
Subscribe our newsletter to stay updated
Copyright © 2023 | Health Issues India | All rights reserved.
